Icomb 5 Mg/10 Mg Capsule Rigide (Ramipril, Amlodipine Besilate)

Ramipril is converted in the body to ramiprilat, which blocks the angiotensin‑converting enzyme, reducing angiotensin II formation and decreasing vasoconstriction and aldosterone‑mediated fluid retention. Amlodipine besilate inhibits L‑type calcium channels in vascular smooth muscle, causing arterial vasodilation. The combined effect produces an additive reduction in peripheral resistance and blood pressure.

The prescribed dose of Icomb is determined by the treating physician based on the patient’s blood‑pressure readings, comorbid conditions, and response to therapy. The product is supplied as a 5 mg ramipril/10 mg amlodipine capsule, and any adjustments are made under medical supervision.

Safety of Icomb in pregnancy and lactation has not been established. ACE inhibitors such as ramipril are generally contraindicated in the second and third trimesters because of fetal toxicity, and the benefits must be weighed against potential risks. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Icomb offers a single‑pill regimen that combines an ACE inhibitor with a calcium‑channel blocker, which can improve adherence compared with taking two separate tablets. Compared with monotherapy, the fixed‑dose combination often achieves greater blood‑pressure reduction and may be preferred when patients need multiple agents to reach target levels.

Store Icomb capsules at ambient temperature below 25 °C in the original blister pack, protected from moisture and direct light. Keep the container tightly closed and out of reach of children. Do not store in a refrigerator or freezer, as temperature extremes can affect capsule integrity.

Icomb is taken orally, usually once daily, with or without food, as directed by a healthcare professional. Swallow the rigid capsule whole; do not crush, chew, or split it, as this could affect the release characteristics of the medication.

Serious adverse reactions include angioedema (swelling of the face, lips, tongue, or airway), severe hypotension leading to fainting, significant liver enzyme elevations, and neutropenia. Patients should seek immediate medical attention if they experience swelling of the throat, sudden dizziness, or signs of infection such as fever with low white‑blood‑cell counts.

Icomb should be avoided in individuals with known hypersensitivity to ramipril, amlodipine, or any excipients in the capsule. It is also contraindicated in patients with a history of angioedema related to ACE‑inhibitor therapy, severe aortic stenosis, or those who are pregnant in the second or third trimester. Clinicians must assess each patient’s medical history before prescribing.